Skip to content

Clinical trials

Recruiting Lung Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Status: Recruiting Country / region: Germany Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20171
20201
20211
20221
20233
20242
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
Eli Lilly and Company2
AIRNA Corporation1
AstraZeneca1
GlaxoSmithKline1
Grifols Therapeutics LLC1
Iovance Biotherapeutics, Inc.1
Nuvalent Inc.1
Revolution Medicines, Inc.1
Taiho Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases16
Respiratory Tract Diseases7
Carcinoma, Non-Small-Cell Lung6
Lung Neoplasms6
Bronchial Neoplasms4
COVID-194
Carcinoma4
Respiratory Tract Infections4
Coronavirus Infections3
Emphysema3

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.